IntelliDex Rx
New standard in drug knowledge support: adv. comp. linguistics, NLP, analytics gives precise, visually-cued drug decision info. & insight.
- Stage Prototype Ready
- Industry IT Services
- Location Arroyo Grande, CA, USA
- Currency USD
- Founded November 2011
- Employees 9
- Website intellidex.biz
Company Summary
Product supports drug related decisions by assisting clinical professionals to discover, synthesize & understand latest drug info & research at 50 pgs/sec in 9 languages. Benefits: 10-30% cost saving, improve quality & safety of patient care outcomes, reduce litigation costs, & significantly reduce med errors. Market:16,598 U.S. health care delivery inst., group med practices, insurors, research, educ., life sciences, govt-domestic & global.
Team
-
Alan E. Cremer, Ed.D.CoFounder & EVP Corporate Developmentnt
Alan brings more than 25 years experience in Organizational Development & HR mgt in IT healthcare start-ups & early stage companies to IntelliDex Rx. Trained as an Industrial Psychologist Alan was a faculty member a Harvard Medical School for 22 years. Specialties include: OD, HR, restructuring corporations, executive consultation to Boards and Senior Mgt. Education: Babson College, Suffolk University, Boston University, Harvard Medical School.
-
Rudy F. Xavier, M.S.Co-Founder & COO
Rudy was part of a Fortune 100 Company team that developed the core technology on which IntelliDex Rx is built. Rudy brings specific application design & development experience to the Company based on his technical systems & medical training. Rudy has a unique perspective, transitioning from code development to sales of specialized AI-based software. Experienced at several start-up software companies. Education: Fulbright scholar, Southern IL U.
-
Alan F. Dowling, Ph.D.CEO & President
Alan is also Adj. Prof. at Case Western University. Areas of expertise: health bus & info strategies, process & product innovation, health IT applications, transfer & adolption, M&A, channel distribution & global health systems. Prior E&Y Partner for Health Care IS & Global Health Care Consulting Practices. Managed pre-angel start-ups through health systems, lg corps & govt. in U.S & internationally. Education: Holy Cross, U of Dayton, & MIT
-
David A. Butler, MBACFO
David has been CFO of 2 publically traded companies; Sequoia Systems where he led the financial & administrative groups from pre-revenue state to a multinational, public company with revenues exceeding $100M & Biopure. He also has worked with smaller early stage/growth public and private companies on revenue recognition, valuations, ownership transition planning as a financial consultant. Education: Boston University.
-
Richard P. Goodkin, Esq.Corporate Counsel
Richard has more than 35 years experience as General Counsel for several major public and private high-tech corps. Legal background includes domestic & international negotiations, IPO leadership, licensing, litigation, contracts, bids and employee issues. Previously cofounder of UniCad which he successfully sold for $10M. Richard is an angel investor in several private medical healthcare start-ups. Education: Princeton and Harvard Law School.
Advisors
-
Dr. Bruce Canaday Pharm. D.Advisory Board - Clinical Pharmacology & Processes AdvisorUnconfirmedClinical Pharmacology & Process AdvisorJanet Hofmeister, Pharm D.Advisory Board - Clinical Pharmacology & Process AdvisorUnconfirmed
-
Neeraj L. Khanna, B.S.E.E. (Honors)Advisory Board Technical AdvisorUnconfirmedGail M. McFaddin, Ma.P.A.Advisory Board - Market AdvisorUnconfirmedJim Medeiros, B.S.E.E.Advisory Board - Product Management AdvisorUnconfirmed
Previous Investors
-
Dr. Besie Hazard MDUnconfirmedMichael LoftusUnconfirmedFamily & FriendsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.